Novo Nordisk A/S (NVO) Social Stream



Novo Nordisk A/S (NVO): $107.75

3.70 (+3.56%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Novo Nordisk A S (NVO) Price Targets From Analysts

Use the tables below to see what analysts covering Novo Nordisk A S think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 4 $118.8 $115 $116.9 $112.91 3.53%
2022-02-09 4 $118.8 $115 $116.9 $112.91 3.53%

The Trend in the Analyst Price Target


Over the past 20 months, NVO's average price target has gone up $50.62.

NVO reports an average of 11.38% for its upside potential over the past 97 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-04 4 118.8 115 116.9 115.85 0.91%
2021-12-27 4 118.8 115 116.9 111.63 4.72%
2022-01-03 4 118.8 115 116.9 108.79 7.45%
2022-01-05 4 118.8 115 116.9 102.54 14%
2022-02-02 4 118.8 115 116.9 106.59 9.67%

NVO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.75 1 0 2 0 0 4

The Trend in the Broker Recommendations


NVO's average broker recommendation rating worsened by 0.44 over the prior 16 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • NVO has a greater number of analysts covering the stock than 0.22% of stocks in the mega market cap category.
  • In terms of how Novo Nordisk A S fares relative to stocks in the mega market cap category, note that its variance in analysts' estimates is lower than 98.79% of that group.
  • In terms of how Novo Nordisk A S fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 4.44% of that group.
  • NVO has a greater average analyst price target than 87.68% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Novo Nordisk A S are MRK, LLY, and JNJ.

Make investment decisions regarding NVO using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.3728 seconds.